<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Maternal serum human chorionic gonadotrophin (hCG) levels were measured during the second and the third trimesters of pregnancy in patients with either <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) or <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> results were expressed in multiples of the gestation-specific <z:mpath ids='MPATH_458'>normal</z:mpath> medians (MoM) </plain></SENT>
<SENT sid="2" pm="."><plain>The median MoM level in 17 samples from SLE patients was 1.48 compared with 0.79 MoM in 99 controls of similar gestation (p &lt; 0.002, Wilcoxon Rank sum test) </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast the median MoM level in 19 samples from primary APS patients was only 1.14 </plain></SENT>
<SENT sid="4" pm="."><plain>These preliminary findings should be further studied to evaluate the implications for <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> screening, detection of SLE cases during pregnancy and the prediction of adverse outcome in SLE gestations </plain></SENT>
</text></document>